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Ubiquitination modifies proteins in a variety of ways, the 
significance of which we only partially comprehend. 
Ubiquitin can be attached: as an individual moiety to a 
single or multiple lysine residues of substrate (mono- or 
multiple monoubiquitination); as chains of ubiquitin 
moieties that are interlinked through any one of the 
seven lysine residues of ubiquitin (for example K48- or 
K63-linked chains); or as branched chains, to name but a 
few [1]. The cell interprets each of these modifications as 
a distinct signal. The first described role of ubiquitination 
as mediating protein degradation through targeting to 
the proteasome has now been complemented with 
numerous other functions [2]. For example, the signal 
encoded by K63-linked chains can mediate functions as 
diverse as receptor endocytosis [3,4], activation of 
protein kinases in the NF-κB pathway and the initiation 
of error-free DNA repair [2].
Signal transduction from transmembrane cell surface 
receptors to nuclear transcription factors is regulated at 
multiple levels by protein ubiquitination. The covalent 
attachment of one, or often more, ubiquitin moieties has 
emerged as the principal mechanism for termination of 
signaling, by targeting the receptor for endocytosis and, 
ultimately, degradation in the lysosome [3]. This device 
controls a vast array of mammalian signaling receptors, 
such as receptor tyrosine kinases, G-protein coupled 
receptors (GPCRs), growth hormone receptors, the 
major histocompatibility complex I, NOTCH, various 
channels and transporters, and cytokine and interferon 
receptors [3]. Receptors that are internalized after 
activation are directed first into the endosomes of the 
endocytic pathway, and then into multivesicular bodies 
(MVBs), which undergo a process of maturation that 
ends with fusion with the lysosome and delivery of the 
contents for degradation. Ubiquitination of the receptor 
provides the crucial signal for entering this pathway 
[3,5-7].
Subsequent delivery of membrane receptors to the 
lysosome requires accurate recognition of the 
ubiquitinated cargo by endosomal adaptors and sorting 
proteins. For the EGF receptor, for example, these are 
EPS15, epsin and ESCRTs (endosomal sorting complexes 
required for transport), which contain one or more 
ubiquitin-binding domains (UBDs) [8]. EPS15 and epsins 
act at the initial steps of internalization, serving to recruit 
the enzymes required for ubiquitination of downstream 
components of the endocytic pathway. ESCRTs act 
sequentially at various points of the degradative route, 
sorting the ubiquitinated cargo at the endosomal 
membrane for inclusion into the intraluminal vesicle of 
the MVB. ESCRT-0, composed of the two interacting 
proteins HRS and STAM, is the first in this process. 
Three additional complexes, ESCRT-I, ESCRTII and 
ESCRT-III, are then involved in the generation of inward 
vesicle budding, which is required for MVB maturation 
(for reviews see [5,9]). The ubiquitin-binding ‘route 
controllers’ that operate in this way to ferry the 
internalized receptor inexorably towards a degradative 
fate in lysosomes are also inducibly ubiquitinated [10,11] 
(Figure 1).
The inducibility of the system illustrates the dynamic 
nature of ubiquitin-based endocytic regulation. Indeed, 
over the past 15 years, studies from different laboratories 
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have revealed a critical role for ubiquitination in receptor 
down-regulation, a process that is essential for the spatial 
and temporal resolution of receptor signaling [3].
The central component of this regulatory pathway is 
the E3 ligase that attaches the ubiquitin molecules to the 
receptor, or to the ubiquitin-binding endocytic adaptors 
(Figure 1). A hierarchical set of three types of enzyme is 
required for substrate ubiquitination: ubiquitin-
activating (E1), ubiquitin-conjugating (E2) and ubiquitin-
protein ligase (E3) enzymes. In mammals two E1-
activating enzyme transfer ubiquitin to roughly three 
dozen E2s, which function together with several hundred 
different E3 ubiquitin ligases to ubiquitinate thousands of 
substrates. In the endocytic pathway distinct E3 enzymes 
generally catalyze the ubiquitination of the cell-surface 
receptors and the endosomal sorting proteins [3]. 
Therefore the endocytic sorting of a given target generally 
involves more than one E3 ubiquitin protein ligase.
Here we focus on how signaling controls the activity of 
the E3 ligases that ubiquitinate receptors and endocytic 
adaptors. Although E3 ligases have largely been 
considered to be constitutively active and regulated only 
at the level of target binding, it has recently become 
evident that they are subject to regulation by either E3 or 
substrate phosphorylation, or by exploitation of adaptor 
proteins that facilitate E3 activity. We discuss here the 
various ways of regulating E3 ligases in the context of 
endocytosis.
Ligand-induced E3 ligases for receptor 
ubiquitination
Protein phosphorylation, which is well known to function 
in recruitment of the ubiquitination machinery to the 
substrate [12], may also act directly to regulate the 
activity of distinct ubiquitin ligases.
The best-characterized circuitry involves the E3 ligase 
Cbl, which is responsible for the ubiquitination of several 
receptor tyrosine kinases (RTKs) [3]. The mammalian 
Cbl protein family consists of the three homologs c-Cbl, 
Cbl-b, and Cbl-3, all of which associate with a wide 
variety of signaling proteins [13]. Two highly conserved 
amino-terminal domains contribute strongly to E3 
regulatory function. First, the amino-terminal tyrosine 
kinase binding (TKB) domain of Cbl recognizes 
phosphotyrosine residues and allows Cbl to interact 
directly with activated RTKs at the plasma membrane 
(Figure 2). Second, the RING finger domain recruits 
ubiquitin-loaded E2s, whose interaction with Cbl results 
in the ubiquitination and subsequent degradation of the 
associated RTK. In the case of the epidermal growth 
factor receptor (EGFR) and the hepatocyte growth factor 
receptor MET, the molecular mechanism of receptor 
ubiquitination has been investigated in detail. In both 
cases, Cbl binds directly to phosphotyrosine (pY)-sites on 
the activated receptor through its TKB [14,15], as well as 
indirectly through its constitutive partner GRB2, which is 
recruited to receptors via other pY sites [7,16-18]. Both 
direct and indirect interactions of Cbl with the EGFR or 
MET are required for full ubiquitination of these 
receptors (Figure 2). Once bound, the ligase is 
phosphorylated and consequently activated [19]. Two 
Figure 1. Receptor internalization and the role of ubiquitin. The 
example shown here is that of the EGF receptor. An activated EGFR 
is ubiquitinated at the plasma membrane and recruits the endocytic 
adaptor proteins EPS15 and EPSIN-1. These are ubiquitinated, in 
turn, and direct the internalized receptor to the endosomal pathway 
where it binds the sorting protein HRS. This is also ubiquitinated and 
directs progression of the ubiquitinated receptors towards lysosomal 
degradation through the ESCRT complexes. For simplicity, the EGF 
receptor is depicted as monoubiquitinated: in reality, it is both 
multimono- and polyubiquitinated. MVB, multivesicular body.
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structural studies have now shed light on the mechanism 
of phosphorylation-induced activation of c-Cbl and 
Cbl-b [20,21]. In the absence of substrate binding, the 
TKB and RING domains form a compact structure that 
masks the E2 binding site. Binding of the TKB to the 
substrate induces a first rotation of the linker region, 
allowing phosphorylation of tyrosine 371 (363 in Cbl-b). 
This phosphorylation event induces a complete rotation 
of the linker region that unmasks the RING E2 binding 
surface and activates the ligase [20,21].
Another class of E3 ligases, the HECT NEDD4 family 
[22], whose regulation has been extensively studied, also 
regulates endocytosis and sorting of numerous signaling 
receptors [3,5-7]. These enzymes present a conserved 
modular organization with an amino-terminal C2 
domain that is crucial for membrane localization, 
between two and four WW domains capable of 
recognizing substrates and adaptor proteins through PY 
motifs, and a carboxy-terminal catalytic HECT domain. 
In contrast to RING-based ligases in which the RING is 
an allosteric activator of the E2, HECT-containing E3s 
have intrinsic catalytic activity and directly ubiquitinate 
their targets. In humans, there are nine members of this 
family: NEDD4 (also known as NEDD4-1), NEDD4L 
(also known as NEDD4-2), ITCH (also known as AIP4), 
WWP1, WWP2, SMURF1, SMURF2, NEDL1 (also 
known as HECW1) and NEDL2 (also known as HECW2). 
Rsp5 is the unique, essential member of the NEDD4 
family in Saccharomyces cerevisiae. In normal conditions 
most of them appear to be in an inactive state because of 
an intramolecular inhibitory interaction between the 
carboxy-terminal HECT and the amino-terminal C2 
domain (in the case of SMURF2, NEDD4 and WWP2 
[23]) or the WW domains (in the case of ITCH [24]). 
Activation of this class of enzyme can occur in various 
ways that are briefly described below.
ITCH is the E3 ligase for the chemokine receptor 
CXCR4 [25]. The ubiquitin moiety on CXCR4 serves as a 
signal on endosomes for entry into the degradative 
pathway and long-term attenuation or downregulation of 
signaling [25]. ITCH can interact directly with CXCR4 
through a non-canonical WW domain-mediated 
interaction involving serine residues within the carboxy-
terminal tail of CXCR4. These serine residues are 
phosphorylated upon agonist activation, and are critical 
for mediating agonist-promoted binding of ITCH and the 
subsequent ubiquitination and degradation of CXCR4 
[26] (Figure 3a). Also in this case, the ligase appears to be 
regulated by phosphorylation. ITCH phosphorylation is 
activated by JNK1 [24], and is thought to lead to 
Figure 2. EGFR ubiquitination by Cbl. Upon EGF-dependent receptor activation, the GRB2-Cbl complex binds to the receptor through 
interactions of: i) the SH2 domain of GRB2 with pY1045 of EGFR, and ii) the TKB domain of Cbl (either c-Cbl or Cbl-b) with pY1068 or pY1086. 
This substrate interaction may either stabilize or select for a partially open Cbl conformation (see bottom panel and main text). EGFR-bound Cbl 
becomes phosphorylated on a critical tyrosine, leading to full rotation of the linker region. This, in turn, exposes the RING domain for ubiquitin-
charged E2 binding, resulting in the allosteric activation of the E2 by Cbl and ubiquitination of the EGFR. Note that, to simplify the picture, Cbl 
bound to one receptor molecule is depicted to ubiquitinate the other molecule of the dimer. No available data suggest that this is indeed the case. 
For simplicity, the EGF receptor is depicted as monoubiquitinated: in reality, it is both multimono- and polyubiquitinated.
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conformational changes that disrupt the inhibitory 
intramolecular interactions between its WW and the 
HECT domains.
In the case of SMURF2, autoinhibition of the HECT 
domain by the C2 domain helps in maintaining the 
steady-state levels of this E3 ligase and can be relieved by 
adaptor-mediated substrate targeting [23]. SMURF1 and 
SMURF2 bind to TGF-β family receptors through the 
inhibitory Smad proteins, SMAD6 and SMAD7, to 
induce their ubiquitin-dependent degradation. Wiesner 
et al. [23] demonstrated that intramolecular interactions 
between the C2 and HECT inhibit SMURF2 catalytic 
activity interfering with ubiquitin thioester formation. 
This in cis autoinhibition can be relieved by binding of 
the amino-terminal domain (NTD) of the adaptor 
protein SMAD7 to the E3 HECT domain (Figure 3b). The 
SMAD7 NTD further enhances the catalytic activity of 
the SMURF2 ligase by recruiting the E2 UbcH7 to the 
HECT domain [27]. By releasing C2-mediated 
autoinhibition, stimulating E2 binding, and recruiting 
SMURF targets, SMAD7 functions at multiple levels to 
control E3 activity and ensure specificity in SMURF-
catalyzed ubiquitination.
Recently, a role for a UBD present on the N-lobe of the 
HECT domain of NEDD4 and Rsp5 has been identified 
[28,29]. The ability of the HECT domain to bind non-
covalently to the distal ubiquitin at the growing end of 
the polyubiquitin chain on the substrate allows enzyme 
Figure 3. Activation of E3 ubiquitin ligases through recruitment to activated receptors. (a) Ubiquitination of CXCR4 by ITCH. ITCH activity 
is inhibited as a result of the intramolecular interaction between the WW domain and the carboxy-terminal catalytic HECT domain. Upon 
agonist-mediated activation, CXCR4 becomes phosphorylated at Ser324 and Ser325 by an unknown kinase. This leads to the recruitment of 
the ITCH, through its WW domain, and consequent release of the inhibitory intramolecular interaction, allowing ubiquitination of the receptor. 
(b) Ubiquitination of the TGF-β receptor by the SMURF2-SMAD7 complex. SMURF2 activity is inhibited as a result of the intramolecular interaction 
between the amino-terminal C2 and the carboxy-terminal catalytic HECT domain. The interaction with SMAD7 NTD displaces the C2 domain 
of SMURF2 from the HECT domain and activates the ligase. The activated SMURF2-SMAD7 complex associates with activated TGF-β receptor 
complexes at the membrane via the displaced C2 domain, causing receptor ubiquitination.
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processivity [28]. It is tempting to attribute an inhibitory 
role of the C2 binding for this critical feature of these 
enzymes. Accessibility of the UBD may be restored in 
response to upstream signaling events capable of inducing 
phosphorylation and/or ubiquitination of critical sites in 
the C2 or in the HECT domain, leading to full ligase 
activation. While this hypothesis needs to be experimentally 
verified, we notice that ubiquitination of NEDD4 is a 
critical event for the coupled monoubiquitination of 
EPS15 ([30] and below).
In some cases, such as for the epithelial Na+ channel 
(ENaC), receptor:ligase interaction – and consequent 
receptor ubiquitination – is the default pathway, with 
phosphorylation negatively regulating ligase activity. 
NEDD4-2 binds constitutively to ENaC PPxY-containing 
motifs and catalyzes its ubiquitination, internalization 
and lysosomal targeting. This prevents Na+ overload in 
epithelial cells and is necessary for the maintenance of 
salt and fluid balance in the body. To increase ENaC 
abundance at the surface and enhance epithelial Na+ 
absorption, NEDD4-2 is phosphorylated by various 
kinases, including protein kinase A (PKA), serum- and 
glucocorticoid-inducible kinase (SGK), and IκB kinase 
(IKK)β (Figure 4a). Phosphorylation induces binding of 
14-3-3 proteins, which prevents NEDD4-2 from binding 
to ENaC [31-33].
Regulation of receptor ubiquitination by adaptor 
proteins
Finally, specific binding proteins can regulate the process 
of ubiquitination by acting as adaptors to recruit E3 
proteins to receptors that lack a direct binding motif for 
the ligase (reviewed in [34]). The best evidence for this 
mechanism so far comes from membrane transport 
directed by the yeast HECT E3 ligase Rsp5, which is the 
unique homolog of the mammalian NEDD4 family 
proteins. While in humans there are nine members of the 
NEDD4 family, yeast Rsp5 is sufficient on its own to 
control most membrane traffic ubiquitination events at 
the plasma membrane and at other biomembranes [35]. 
Cooperation with adaptors such as Bul1/Bul2, Bsd2/
Tre1/Tre2, or Ear1/Ssh4 enables Rsp5 to cope with this 
large number of substrates [35], and the discovery of the 
yeast family of ARR-related proteins (ARTs), which direct 
Rsp5 activity to various plasma membrane receptors [36-
38], shows that the adaptor mechanism is even more 
extensive than previously thought (Figure 4b). Does 
receptor signaling regulate these HECT adaptor proteins? 
Figure 4. Regulation of channels and transporters by ubiquitination. (a) ENaC ubiquitination by NEDD4-2. NEDD4-2 binds to PY motifs 
on the epithelial Na+ channel ENaC and catalyzes its ubiquitination. This induces ENaC endocytosis and lysosomal targeting, resulting in fewer 
channels at the cell surface. To increase Na+ transport, NEDD4-2 is phosphorylated by kinases, including PKA, SGK, and IKKβ, in turn activated by 
various signaling pathways. Phosphorylation of NEDD4-2 induces binding of 14-3-3 dimers (not shown), which prevents NEDD4-2 from binding 
to ENaC. As a result, endocytosis of ENaC is inhibited, and increased ENaC presence at the surface enhances epithelial Na+ absorption. (b) Rsp5 
ubiquitinates permeases and transporters. In yeast, arrestin-related endocytic adaptors (ARTs) and the E3 ubiquitin ligase Rsp5 are recruited to the 
plasma membrane in response to environmental stimuli that trigger the endocytosis of proteins such as permeases and transporters (for example, 
the arginine transporter Can1). Through their PY motifs, ARTs bind to the WW domain of Rsp5 and mediate ubiquitination of cargo. ARTs are also 
ubiquitinated by Rsp5, an event required for endocytosis.
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Two recent papers provide evidence that it does [39,40]. 
MacGurn et al. [40] demonstrated that signaling from 
TORC1, which is a central regulator of cell growth in 
response to amino acid availability, regulates Rsp5 
targeting and endocytosis of nutrient transporters at the 
plasma membrane. The effector mechanism that 
regulates endocytosis involves a TORC1-Npr1 negative 
kinase signaling cascade that tunes the phosphoinhibition 
of the ubiquitin ligase adaptor Art1 [40]. Leon and 
colleagues [39] identified the α-arrestin Rod1/Art4 
as a direct target of the glucose signaling pathway. 
Glucose promotes Rod1/Art4 dephosphorylation and 
its subsequent release from a phospho-dependent 
interaction with 14-3-3 proteins. This allows Rsp5-
mediated Rod1 ubiquitination, a prerequisite for 
transporter endocytosis [39]. It is conceivable that other 
signaling pathways may similarly regulate the activity of 
other ART family proteins.
Does this mechanism also operate in mammals? And if 
yes, how? These important gaps in our understanding 
need to be filled. Of note, arrestin domain containing 
protein 3 (ARRDC3) was recently shown to interact with 
NEDD4 and to be an essential adaptor for β2-adrenergic 
receptor (β2AR) ubiquitination [41].
Ligand-induced E3 ligases for adaptor 
ubiquitination
The adaptors we have just discussed function to recruit 
E3 ligases to receptors. We now return to the endocytic 
adaptors that are recruited to the ubiquitinated receptors 
and direct their subsequent endocytosis. As with direct 
receptor ubiquitination, the ubiquitination of endocytic 
adaptors plays a critical role in endocytosis. The arrestin 
(ARR) family of proteins is able to direct internalization 
of GPCR cargo. Signaling from activated GPCRs is 
terminated when GPCRs are phosphorylated by GPCR 
kinases (GRKs), leading to the recruitment of ARR, 
which binds to AP-2 and clathrin, structural components 
of the vesicles formed at the plasma membrane causing 
the whole complex to be internalized. Agonist-stimulated 
ubiquitination of ARR mediated by the E3 ligase murine 
double minute (MDM2), an important negative regulator 
of p53, is critical for rapid receptor internalization [42]. 
MDM2-ARR binding is constitutive and does not persist 
after receptor activation, suggesting that ubiquitin modi-
fication might cause a conformational change on ARR 
required to promote internalization. GPCRs themselves can 
also be ubiquitinated, most probably by NEDD4, an event 
required for cargo degradation but not internalization [43]. 
Thus by analogy with the ‘phosphorylation code’ on the 
receptor carboxy tail, ubiquitin modifications on both 
adaptors and receptors result in a ‘ubiquitination code’ 
that fine-tunes signal strength, localization, and cellular 
functions of GPCR (Figure 5a).
ARR is not the sole example of an endocytic adaptor 
subjected to ubiquitin modification. Several components of 
the downstream endocytic machinery are monoubiquitinated 
upon RTK activation [10,11,44,45]. In most cases, these 
adaptors are ubiquitin receptors that are ubiquitinated by 
the E3 ligase NEDD4. The presence of a UBD is required 
for monoubiquitination of the UBD-harboring adaptor, 
in a process termed coupled monoubiquitination whose 
molecular workings have been elucidated using the 
endocytic proteins EPS15 and EPSIN-1 as models [30,46] 
(Figure 5b). By contrast, the mechanism by which 
NEDD4 recruitment is induced by the activated EGFR 
remains to be clarified.
What is the role of adaptor ubiquitination? 
Monoubiquitination might permit the formation of 
several tiers of ubiquitination-dependent interactions in 
the endosome, by allowing binding of ubiquitinated cargo 
(through UBDs) and recruiting another layer of ubiquitin 
receptors through the monoubiquitin signal. The result 
would be signal amplification and progression of 
ubiquitinated cargoes along the endocytic pathway.
Monoubiquitination of ubiquitin receptors may also 
result in an intra-molecular interaction between their 
UBDs and monoubiquitinated residues, with resulting 
dissociation from the ubiquitinated cargo [47,48]. These 
two possibilities are not mutually exclusive and both 
mechanisms may be involved in the regulation of 
endocytic processes, possibly by acting at distinct steps 
and/or regulating different endocytic adaptors.
Is the ubiquitination cascade like 
the phosphorylation cascade?
It is important to realize that the power of ubiquitin stems 
from its capacity to act as a protein-protein interaction 
module that targets substrates to a plethora of downstream 
effectors. In order to realize this network, complex molecular 
machines generate and recognize signal diversity based 
on ubiquitin-binding modules. The network is fine-tuned 
by ubiquitinating (E3 ligases) and deubiquitinating 
enzymes (DUBs) that balance the absolute levels of 
protein ubiquitination, as well as the abundance and 
localization of adaptors that contain docking sites for 
specific ubiquitinated proteins (UBDs) [49].
One such network pivots around EGFR. EGF 
stimulation promotes ubiquitination of EGFR and of 
EGFR endocytic adapters, providing a striking example 
of concerted regulation of signaling, ultimately regulating 
the route of EGFR internalization [50,51]. Our own 
approach to understanding the complex interplay 
between EGFR-induced signaling circuitries has been the 
recent elucidation of the EGF-induced ‘ubiproteome’ 
[52]. This work has uncovered an extensive ubiquitin-
based signaling network that impinges on a wide array of 
signaling circuitries and various aspects of cellular 
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physiology including DNA repair, nuclear transport, 
mRNA processing, metabolic pathways, and ribosome 
biogenesis. Interestingly, many ubiquitin machinery 
enzymes were detected in the EGF-induced ubiproteome. 
Regardless of the initial triggering mechanism (which 
necessarily involves the kinase activity of the EGFR), the 
ubiquitin signal seems to be rapidly transmitted to, and 
amplified through, the ubiquitin machinery. Just as in the 
phosphorylation cascade, in which critical enzymes such 
as kinases and phosphatases are often activated by 
phosphorylation, ubiquitinating enzymes appear to be 
regulated by ubiquitination. Moreover, a comparison of 
the EGF-induced ubi- and pY-proteomes revealed a 
significant overlap and identified many highly connected 
‘hub’ proteins that are both phosphorylated and 
ubiquitinated [52]. These data suggest that two 
complementary and interlinked enzymatic cascades drive 
the flow of information from receptors to downstream 
signaling molecules: kinases/phosphatases and E3 
ligases/DUBs. In essence, these two post-translational-
modification-based networks can be conceptualized as 
two overlapping, diffusely interconnected, matrices 
Figure 5. Ubiquitination of adaptors. (a) Agonist induces rapid ubiquitination of GPCR-recruited ARR by MDM2, a process required for receptor 
internalization. Once internalized, GPCRs can be dephosphorylated and rapidly recycled to the plasma membrane through a mechanism that 
involves the sorting proteins EBP50 and NSF. (b) Activated EGFR is ubiquitinated at the plasma membrane by Cbl and recruits the UBD-containing 
endocytic adaptors EPS15 and EPSIN-1 at the plasma membrane, and subsequently HRS at the endosomal membrane. These adaptors, in turn, are 
ubiquitinated by NEDD4 through a process known as coupled monoubiquitination. This directs progression of the ubiquitinated receptors toward 
lysosomal degradation through the ESCRT complexes. A similar mechanism can be envisioned for other RTKs.
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through which external signals are transduced and 
interpreted by the cell. To understand how this is 
achieved, a multidisciplinary approach is required. No 
single ‘omics’ analysis can fully unravel the complexities 
of the system. Complete understanding will be achieved 
only by integrating information from high-resolution 
molecular investigations, ‘omics’ approaches and ‘top-
down’ systems-based modeling.
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